Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
65% 1.5% |
 |
Gilead SciencesGILD |
57% 0% |
 |
Catalyst PharmaceuticalsCPRX |
81% 0% |
 |
Inovio PharmaceuticalsINO |
27% 0% |
 |
Anavex Life SciencesAVXL |
0% 0% |
What Do Calidi Biotherapeutics Employees Think About the Company?
44% of Calidi Biotherapeutics (CLDI) employees currently report a positive business outlook, based on anonymous employee surveys aggregated by AltIndex. This is a moderate reading, with the workforce roughly split on the company’s direction.
The score is roughly flat (+0.0%) over the past three months.
At 44% positive, Calidi Biotherapeutics’s employee business outlook trails industry peers like Amgen (65%) and Gilead Sciences (57%).
Why Employee Sentiment Matters for CLDI Stock
Employee business outlook can be a leading indicator: the people inside the business see operational changes, leadership decisions, and market shifts before they reach an earnings report. AltIndex feeds Calidi Biotherapeutics’s outlook score into the CLDI AI Score as one of 25+ alternative data signals, weighed alongside hiring, web traffic, and fundamentals.
For other employment signals, see Calidi Biotherapeutics’s job postings, LinkedIn headcount, and overall employee rating.
Month over Month
| Oct 2026 | 44% | |
| Sep 2026 | 44% | |
| Aug 2026 | 44% | |
| Jul 2026 | 44% | |
| Jun 2026 | 44% | |
| May 2026 | 44% |
Calidi Biotherapeutics Employee Business Outlook: Frequently Asked Questions
44% of Calidi Biotherapeutics employees report a positive business outlook. This is based on anonymous employee surveys aggregated by AltIndex and updated regularly.
A 44% reading is moderate — Calidi Biotherapeutics’s workforce is roughly split on the company’s direction, neither strongly optimistic nor pessimistic.
No single signal predicts a stock on its own, but employee business outlook can be a leading indicator: employees see operational changes, morale shifts, and strategic pivots before they appear in quarterly earnings. AltIndex combines it with 25+ other signals in the CLDI AI Score rather than reading any one signal in isolation.
Compared to its peers, Calidi Biotherapeutics ranks in the 44th percentile when it comes to Business Outlook.
There has been no meaningful change in the business outlook amongst employees at Calidi Biotherapeutics.
Sign up and get more insights on the business outlook at Calidi Biotherapeutics.
See Calidi Biotherapeutics’s complete business outlook history
Sign up to unlock 1-year and all-time charts for CLDI, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
